Biocryst Pharmaceuticals buy HC Wainwright

Summary

This prediction is currently active. The prediction for Biocryst Pharmaceuticals disappoints with a performance of -25.78%. This prediction currently runs until 25.02.26. The prediction end date can be changed by HC_Wainwright at any time. HC_Wainwright has 50% into this prediction

Performance without dividends (%)

Name	1w	1m
Biocryst Pharmaceuticals	5.823%	5.823%
iShares Core DAX®	0,46 %	-1,53 %
iShares Nasdaq 100	-1,79 %	-5,38 %
iShares Nikkei 225®	5,12 %	8,05 %
iShares S&P 500	-1,76 %	-3,82 %